Science Corporation(@ScienceCorp_):Today marks the European launch of PRIMA, the first and only treatment to be commercially available that restores functional central vision to patients with geographic atrophy caused by dry age-related macular degeneration, a leading cause of blindness. The first European commercial implant of PRIMA is expected soon.

Science Corporation

@ScienceCorp_

Building a brighter tomorrow enabled by neural engineering

가입 July 2025

1 팔로잉 중 3.4K 팬

Science Corporation@ScienceCorp_

2026.07.22 13:08

Today marks the European launch of PRIMA, the first and only treatment to be commercially available that restores functional central vision to patients with geographic atrophy caused by dry age-related macular degeneration, a leading cause of blindness. The first European commercial implant of PRIMA is expected soon.